The Purpose of This Study is to Evaluate the Efficacy and Safety of 626 in the Treatment of SLE
Clinical trial NCT07185269 · RECRUITING
Trial details
- NCT number
- NCT07185269
- Sponsor
- Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-09-24
- Primary completion
- 2028-08-12
- Enrollment
- 198
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.